Emerald Innovations

Emerald Innovations is a touchless sensor and machine learning platform designed for health analytics. The company’s sensor monitors users in the home passively, recording, monitoring, and sending data without requiring any interaction. This technology facilitates in-home trials with no added burden to patients or sites, capturing more data in a shorter period. The platform collects reliable metrics related to mobility, gait, behaviors, respiration, sleep quality, and sleep stages. Emerald Innovations’ customers include some of the largest pharmaceutical companies globally, with repeated contracts. The product has been utilized in Phase 2 and Phase 4 clinical trials across neurology, immunology, and rare diseases. The company, headquartered at 1 Broadway 14FL, Cambridge, MA, was founded by MIT faculty and researchers and is bootstrapped, cashflow positive, and 100% employee-owned. Built on years of research by over 50 MIT engineers and scientists, the platform can determine a person’s position, monitor activity levels, and extract in-home gait speed. Using wireless signals, it can also extract breathing signals and sleep stages, discerning deep sleep from dreaming. Recent research indicates the possibility of extracting a 3D skeleton using wireless signals. The platform employs machine learning and signal processing algorithms to detect movements and produce detailed health data and insights. The device continuously analyzes movements and behaviors, uploading data over an encrypted connection to the Emerald Cloud. It provides patient-centric clinical endpoints and real-world evidence representative of a patient’s quality of life. Operating passively, it collects data as patients go about their daily lives, including sleep patterns and stress levels, to assess treatment efficacy and safety. The platform is used in various health monitoring applications, including COVID-19, sleep and musculoskeletal disorders, and pulmonary and neurological diseases. Emerald Innovations presented its technology to President Obama at the White House.